View in EDS PDF Full Text

The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.

Saved in:
Bibliographic Details
Title: The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
Authors: Tunitsky-Lifshitz, Yulia1,2, Maoz-Segal, Ramit1, Niznik, Stanley1, Shavit, Ronen1, Yahia, Soad Haj1,2, Langevitz, Pnina2,3, Agmon-Levin, Nancy1,2 nancy.agmonlevin@sheba.health.gov.il
Source: Lupus. Apr2023, Vol. 32 Issue 5, p675-679. 5p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 164049697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tunitsky-Lifshitz%2C+Yulia%22">Tunitsky-Lifshitz, Yulia</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Maoz-Segal%2C+Ramit%22">Maoz-Segal, Ramit</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Niznik%2C+Stanley%22">Niznik, Stanley</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Shavit%2C+Ronen%22">Shavit, Ronen</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Yahia%2C+Soad+Haj%22">Yahia, Soad Haj</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Langevitz%2C+Pnina%22">Langevitz, Pnina</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Agmon-Levin%2C+Nancy%22">Agmon-Levin, Nancy</searchLink><relatesTo>1,2</relatesTo><i> nancy.agmonlevin@sheba.health.gov.il</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lupus%22">Lupus</searchLink>. Apr2023, Vol. 32 Issue 5, p675-679. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=164049697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/09612033231164262
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 675
    Titles:
      – TitleFull: The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tunitsky-Lifshitz, Yulia
      – PersonEntity:
          Name:
            NameFull: Maoz-Segal, Ramit
      – PersonEntity:
          Name:
            NameFull: Niznik, Stanley
      – PersonEntity:
          Name:
            NameFull: Shavit, Ronen
      – PersonEntity:
          Name:
            NameFull: Yahia, Soad Haj
      – PersonEntity:
          Name:
            NameFull: Langevitz, Pnina
      – PersonEntity:
          Name:
            NameFull: Agmon-Levin, Nancy
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: Apr2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09612033
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Lupus
              Type: main
ResultId 1